What is Specim?
Established in 1995, Specim is a leader in developing and supplying high-performance hyperspectral cameras and integrated systems. Their advanced solutions cater to a wide array of industries, laboratories, and field applications, including industrial sorting, inspection, and critical research endeavors. By offering specialized hyperspectral cameras, airborne systems, and sophisticated imaging software, Specim empowers original equipment manufacturers (OEMs), system integrators, and research institutions to optimize processes and achieve enhanced material identification. The company's core mission is to push the boundaries of hyperspectral imaging, revealing insights and material properties that are imperceptible to the naked eye.
How much funding has Specim raised?
Specim has raised a total of $10.1M across 2 funding rounds:
Unspecified
$6M
Private Equity
$4.1M
Unspecified (2015): $6M with participation from Teknoventure Oy and Tekes
Private Equity (2017): $4.1M led by Bocap Private Equity
Key Investors in Specim
Teknoventure Oy
Teknoventure Oy is an independent Finnish firm specializing in advisory services for corporate ownership, mergers, and acquisitions, with a strong network in Finland and Sweden. They provide strategic management and corporate finance expertise, often arranging equity financing for growing companies.
Tekes
Tekes, now Business Finland, offers funding for researchers to commercialize ideas, focusing on identifying customers and developing viable routes for commercial success through projects like TUTL.
Bocap Private Equity
Bocap is an independent Finnish private equity firm focused on accelerating the growth of competitive Finnish SMEs by providing strategic and operational support, typically investing between 3 to 10 million euros.
What's next for Specim?
With a history of significant enterprise-level funding, Specim is well-positioned for continued growth and innovation in the hyperspectral imaging market. The recent strategic investment, following earlier rounds of financing, suggests a strong market validation and confidence in the company's technological advancements and business strategy. This capital infusion is likely to fuel further research and development, expansion into new markets, and enhancement of their product offerings, solidifying Specim's role as a key player in enabling advanced material analysis and process optimization across diverse industrial and scientific sectors.
See full Specim company page
